Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

Failure of Empirical Systemic Antifungal Therapy in Mechanically Ventilated Critically Ill Patients

(2015) Sébastien Bailly et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin

(2014) Fernando César Bizerra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isolation of cholesterol-dependent, multidrug-resistant Candida glabratastrains from blood cultures of a candidemia patient in Kuwait

(2014) Ziauddin Khan et al.   BMC INFECTIOUS DISEASES

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

(2014) Jose Vazquez et al.   BMC INFECTIOUS DISEASES

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

(2014) L. Ostrosky-Zeichner et al.   CLINICAL INFECTIOUS DISEASES

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

(2014) A. Fekkar et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality

(2014) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later

(2014) Philippe Eggimann et al.   INTENSIVE CARE MEDICINE

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)

(2014) Olivier Lortholary et al.   INTENSIVE CARE MEDICINE

Management bundles for candidaemia: the impact of compliance on clinical outcomes

(2014) Y. Takesue et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC

(2014) T. Saraya et al.   JOURNAL OF CLINICAL MICROBIOLOGY

β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis

(2013) Frederic Tissot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure

(2013) Ryan K. Shields et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

(2013) James S. Lewis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience

(2013) A. M. Bal et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Evaluation of Bactec Mycosis IC/F and Plus Aerobic/F Blood Culture Bottles for Detection of Candida in the Presence of Antifungal Agents

(2013) Robin Köck et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control

(2012) M. Kollef et al.   CLINICAL INFECTIOUS DISEASES

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Systemic antifungal therapy in critically ill patients without invasive fungal infection*

(2012) Elie Azoulay et al.   CRITICAL CARE MEDICINE

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study

(2012) Alexis Tabah et al.   INTENSIVE CARE MEDICINE

Contrasting treatment-specific survival using double-robust estimators

(2012) Min Zhang et al.   STATISTICS IN MEDICINE

Doubly Robust Estimation of Causal Effects

(2011) Michele Jonsson Funk et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes

(2011) S. A. Grim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study

(2009) Cristóbal León et al.   CRITICAL CARE MEDICINE